Theses: BCI & Neuroscience

Evolving beliefs with evidence. Confidence changes over time as new research arrives.

Thesis 1: Neuralink will have 100+ patients with functional thought-controlled computing by end of 2027

Neuralink has moved from first-in-human to ~20 patients in roughly 18 months, with international expansion to the UK and UAE underway. FDA breakthrough device designation validates the regulatory pathway. The question is no longer whether intracortical BCI works but whether it can scale from research to clinical infrastructure.

Confidence: 5/10 Supporting evidence:

• ~20 PRIME patients currently implanted with thought-controlled computing Evidence: strong (Neuralink PRIME)
• International expansion to UK and UAE indicates regulatory momentum Evidence: moderate (Neuralink PRIME)
• FDA breakthrough device designation validates pathway Evidence: strong (Neuralink PRIME)

Challenging evidence:

• Going from ~20 to 100+ requires 5x scaling of surgical infrastructure in 18 months
• Long-term (5-10 year) electrode biocompatibility is unproven — could limit patient pool
• Each surgery requires specialized neurosurgical teams — not a bottleneck that scales easily
• Cost per implant at research stage is prohibitive for most patients
• Standardized outcome measures across BCI trials do not yet exist
• Regulatory approval in UK/UAE does not guarantee patient volume

Evolution:

• Apr 5, 2026 — Initial thesis at 5/10. The trajectory from 0 to ~20 is encouraging, but surgical scaling is fundamentally different from software scaling. 100+ by end of 2027 requires roughly 4-5 implants per month, which demands multiple surgical centers operating in parallel. Achievable if Neuralink prioritizes it, but not certain.

Depends on: invasive-vs-noninvasive-bci, neuroprosthetics Would change if: Neuralink announces a multi-center surgical expansion, or if electrode degradation issues emerge in early patients.

---

Thesis 2: Speech BCI will restore communication for locked-in patients within 3 years at clinically meaningful accuracy

Two converging breakthroughs make this thesis viable. BIT achieves 10% WER (down from 24.69%) by aligning neural embeddings with audio LLM representations. Stanford demonstrates inner speech decoding from motor cortex, showing that thought patterns are attenuated versions of attempted speech. Together, these open the path from attempted-speech decoding to true thought-to-text communication.

Confidence: 6/10 Supporting evidence:

• BIT framework: 10% WER brain-to-text, down from 24.69% SOTA Evidence: strong (BIT)
• Contrastive learning aligns neural embeddings with audio LLM representations — elegant bridge Evidence: strong (BIT)
• Stanford inner speech decoding from motor cortex, 4 patients Evidence: strong (Stanford)
• Inner speech patterns are attenuated versions of attempted speech — existing BCIs can adapt Evidence: strong (Stanford)
• Synchron's minimally invasive approach could expand patient eligibility Evidence: moderate (Synchron)

Challenging evidence:

• Generalization across patients and recording modalities is unproven
• Real-time performance for practical communication not yet demonstrated
• Open vocabulary vs. constrained vocabularies — clinical use requires open vocabulary
• Privacy implications of inner speech decoding are largely unexplored
• Integration with minimally invasive or non-invasive hardware is an open problem
• "Clinically meaningful" requires >90% accuracy for reliable communication — 10% WER is there but only in controlled settings

Evolution:

• Apr 5, 2026 — Initial thesis at 6/10. The BIT result is remarkable and the Stanford inner speech finding is the conceptual breakthrough that connects these systems to locked-in patients. "Within 3 years" means clinical trials demonstrating practical communication by 2029, not commercial availability. The audio LLM bridge pattern could accelerate progress faster than traditional signal processing approaches.

Depends on: speech-bci, neural-signal-decoding, invasive-vs-noninvasive-bci Would change if: BIT achieves <5% WER in a multi-patient study, or if inner speech decoding proves unreliable outside Stanford's specific electrode placement protocol.